All Articles

In a first for muscular dystrophy, Epicrispr's EPI-321 didn't just slow the disease—it increased lean muscle volume, signaling a new era for gene therapy.

Nasdaq-listed Jinxin Technology is betting its future on AI companions, moving from content to hardware to capture a slice of China's booming children's AI market.

As clients demand simplicity, Clever, GLGR, and The Right Now merge to form Punch Group, betting that an integrated model is the future of marketing.

A new partnership between Remote and isolved embeds global hiring into a major US HR platform, turning international expansion from a legal maze into a simple click.

Fresh off a reverse merger, American Gold & Copper Inc. pivots to US soil, signing a deal for a promising copper-gold project in Nevada's famed Battle Mountain.

As Ontario's lowest-paid nurses demand fair wages from the Victorian Order of Nurses, their fight exposes a deep crisis threatening the province's home-care strategy.

A proxy fight pits Vaxart's experienced board against dissident shareholders demanding accountability, with the future of its innovative pill vaccines at stake.

Upexi joins the Russell Microcap Index, a milestone for any firm. But with a treasury heavy on volatile Solana, is this a new model for investors or a cautionary tale?

How did a single Korean serum dethrone skincare giants on Amazon? Meditherapy's rise reveals a new blueprint for brand building in the digital age.

A new Redfin survey reveals overwhelming bipartisan support for housing affordability policies, creating a powerful public mandate for a landmark bill now stalled.

The Subaru Ascent's top quality award is more than a trophy. It's a look into how corporate values, from the factory floor to the family car, build trust.

First Responders Children's Foundation and T-Mobile are disrupting recognition by letting the public nominate heroes, a strategic shift in community engagement.

A rare disease drug's EU approval is revoked over 'misleading' data, impacting patients and signaling a new era of strict regulatory scrutiny for pharma giants.

After a tumultuous delisting from Nasdaq, Luna Innovations finds a new home with TJC, trading public market woes for private equity's deep pockets.

A landmark trial in Hawaiʻi brings together a tech innovator, a regional airline, and a legacy carrier to test the future of electric island hopping.

As law firms face complex rules and fierce competition, generalist marketers are being dismissed. A look at why specialists like MileMark are the new counsel.

i-80 Gold issues $4.8M in shares to exit a restrictive sales contract, a calculated bet on higher gold prices and its ambitious Nevada growth strategy.

At Europe's top energy expo, Fox ESS didn't just show new hardware; it revealed a calculated strategy of AI integration and market saturation. Is this the new blueprint?

A new report reveals a startling shift: nearly half of Americans are cash-poor, and a growing number of them are middle-class, full-time workers.

The #HMC2026 conference revealed a Malaysian hospitality sector in deep recalibration, moving beyond old playbooks to forge resilience for its next growth era.